![Francine Gregoire](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Francine Gregoire worked as Senior Vice President & Head-In Vivo Programs at Beam Therapeutics, Inc. from 2018 to 2022.
Prior to that, she was Head-Rare Diseases at Moderna, Inc. from 2013 to 2016.
Dr. Gregoire holds a doctorate degree from Katholieke Universiteit Leuven.
Anciens postes connus de Francine Gregoire
| Sociétés | Poste | Fin |
|---|---|---|
| BEAM THERAPEUTICS INC. | Corporate Officer/Principal | 01/12/2022 |
| MODERNA, INC. | Corporate Officer/Principal | 01/03/2016 |
Formation de Francine Gregoire
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
